论著

131I相关唾液腺炎的炎症分级及内镜治疗

  • 李潇 ,
  • 苏家增 ,
  • 张严妍 ,
  • 张丽琪 ,
  • 张亚琼 ,
  • 柳登高 ,
  • 俞光岩
展开
  • 1. 北京大学口腔医学院?口腔医院,口腔颌面外科,北京 100081
    2. 北京大学口腔医学院?口腔医院,放射科 国家口腔疾病临床医学研究中心 口腔数字化医疗技术和材料国家工程实验室 口腔数字医学北京市重点实验室,北京 100081

收稿日期: 2019-02-01

  网络出版日期: 2020-06-30

基金资助

国家自然科学基金(81974151)

Inflammation grading and sialoendoscopic treatment of131I radioiodine-induced sialadenitis

  • Xiao LI ,
  • Jia-zeng SU ,
  • Yan-yan ZHANG ,
  • Li-qi ZHANG ,
  • Ya-qiong ZHANG ,
  • Deng-gao LIU ,
  • Guang-yan YU
Expand
  • 1. Department of Oral and Maxillofacial Surgery
    2. Department of Oral Radiology, Peking University School and Hospital of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China

Received date: 2019-02-01

  Online published: 2020-06-30

Supported by

National Natural Science Foundation of China(81974151)

摘要

目的 结合唾液腺造影及内镜表现对131I相关唾液腺炎进行炎症分级,评估分析内镜治疗的疗效。 方法 收集2012年11月至2018年10月间在北京大学口腔医院进行唾液腺内镜检查与治疗的131I相关唾液腺炎患者的临床及影像学资料,分析唾液腺造影与内镜表现的特点并进行炎症分级。根据病变程度,采取内镜下生理盐水与地塞米松混合液灌洗、机械扩张等治疗,术后进行随访。 结果 42例131I相关唾液腺炎患者中,男性5例、女性37例,男女比例为1 ∶7.4,症状为唾液腺区反复肿胀、疼痛或口干等。腮腺造影主要表现为一处或多处导管狭窄,部分病例分支导管未显影。唾液腺内镜主要表现为导管不同程度狭窄,可见分支导管闭锁。根据腮腺造影及内镜所见分为3级:(1)轻度炎症:主导管存在狭窄和扩张,但0.9 mm内镜可通过;(2)中度炎症:主导管存在一处重度狭窄,内镜不能直接通过;(3)重度炎症:主导管存在2处以上重度狭窄、弥漫性狭窄或导管闭锁。33例(65侧)131I相关唾液腺炎患者的腮腺同时接受唾液腺造影与内镜检查,其中轻度炎症8侧,中度炎症23侧,重度炎症34侧。内镜治疗后经3~72个月随访,效果评价为显效22侧,缓解22侧,无效19侧,失访2侧,总有效率为69.8%。 结论131I相关唾液腺炎的临床、腮腺造影以及唾液腺内镜表现具有明确的特点,据此我们提出131I相关唾液腺炎炎症严重程度的分级标准。唾液腺内镜技术可以明显缓解131I相关唾液腺炎患者的主观临床症状,对于早期病变效果更佳。

本文引用格式

李潇 , 苏家增 , 张严妍 , 张丽琪 , 张亚琼 , 柳登高 , 俞光岩 . 131I相关唾液腺炎的炎症分级及内镜治疗[J]. 北京大学学报(医学版), 2020 , 52(3) : 586 -590 . DOI: 10.19723/j.issn.1671-167X.2020.03.029

Abstract

Objective: To investigate the inflammation grading of131I radioiodine-induced sialadenitis based upon sialoendoscopic and sialographic appearances, and to evaluate the results of sialoendoscopic intervention.Methods: The patients diagnosed with131I radioiodine-induced sialadenitis and underwent sialoendoscopic exploration and intervention procedures in Peking University Hospital of Stomatology from Nov. 2012 to Oct. 2018 were included in this study. The appearances of sialogaphy and sialoendoscopy were analyzed and classified. The treatment options included irrigation with saline and dexamethasone and mechanical dilatation by sialoendoscope. The patients were followed up after treatment.Results: Forty-two patients with131I radioiodine-induced sialadenitis were included. There were 5 males and 37 females, with a male-to-female ratio of 1 ∶7.4. Symptoms included recurrent swelling and pain in the parotid glands, and dry mouth. Sialography showed stenosis in the main duct,and in some cases nonvisua-lization of the branches. Sialoendoscopy showed narrowing of the main duct, and the branch duct atresia was seen. The appearances of sialogaphy and sialoendoscopy were analyzed and classified into 3 groups: (1) Mild inflammation: stenosis and ectasia occurred in the main duct, whereas the 0.9 mm sialoendoscope could pass through easily. (2) Moderate inflammation: one point of severe stricture could be seen in the main duct where 0.9 mm sialoendoscope could not be passed through. (3) Severe inflammation: two points or more of severe strictures or diffused strictures occurred in the main duct. Thirty-three patients with 65 affected glands were examined by both sialography and sialoendoscopy. Eight glands were classified as mild inflammation, 23 glands moderate inflammation, and 34 glands severe inflammation. The duration of follow-up ranged from 3-72 months. The clinical results were evaluated as good in 22 glands, fair in 22 glands, and poor in 19 glands, with an overall effective rate of 69.8% (44/63).Conclusion: The clinical, sialographic and sialoendoscopic appearances of131I radioiodine-induced sialadenitis showed their characteristics. We proposed an inflammation grading standard for the131I radioiodine-induced sialadenitis based on the appearances of sialography and sialoendoscopy. Sialoendoscopy can significantly alleviate the clinical symptoms, which is an effective therapy, and better for early lesions.

参考文献

[1] van Nostrand D. The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer[J]. Thyroid, 2009,19(12):1381-1391.
[2] Lu L, Shan F, Li W, et al. Short-term side effects after radioiodine treatment in patients with differentiated thyroid cancer[J]. Biomed Res Int, 2016,2016(9):1-5.
[3] De Luca R, Vicidomini A, Trodella M, et al. Sialoendoscopy: A viable treatment for I131 induced sialoadenitis [J]. Br J Oral Maxillofac Surg, 2014,52(7):641-646.
[4] 柳登高, 郭玉娇, 姜岚, 等. 43例慢性阻塞性腮腺炎内镜治疗疗效观察[J]. 中华口腔医学杂志, 2012,47(9):81-84.
[5] Ish-Shalom S, Durleshter L, Segal E, et al. Sialochemical and oxidative analyses in radioactive131I-treated patients with thyroid carcinoma [J]. Eur J Endocrinol, 2008,158(5):677-681.
[6] Badam RK, Suram J, Babu DB, et al. Assessment of salivary gland function using salivary scintigraphy in pre and post radioactive iodine therapy in diagnosed thyroid carcinoma patients[J]. J Clin Diagn Res, 2016,10(1):60-62.
[7] Ali MJ. Iodine-131 therapy and nasolacrimal duct obstructions: What we know and what we need to know[J]. Ophthalmic Plast Reconstr Surg, 2016,32(4):243-248.
[8] Maruoka Y, Baba S, Isoda T, et al. A functional scoring system based on salivary gland scintigraphy for evaluating salivary gland dysfunction secondary to 131I therapy in patients with differentiated thyroid carcinoma [J]. J Clin Diagn Res, 2017, 11(8): TC23-TC28.
[9] Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review[J]. Endocr Relat Cancer, 2005,12(4):773-803.
[10] Wu CB, Xi H, Zhou Q, et al. Sialendoscopy-assisted treatment for radioiodine-induced sialadenitis[J]. J Oral Maxillofac Surg, 2015,73(3):475-481.
[11] Allweiss P, Braunstein GD, Katz A, et al. Sialadenitis following131I therapy for thyroid carcinoma: Concise communication [J]. J Nucl Med, 1984,25(7):755-758.
[12] Silberstein EB. Reducing the incidence of131I-induced sialadenitis: the role of pilocarpine [J]. J Nucl Med, 2008,49(4):546-549.
[13] Ko KY, Kao CH, Lin CL, et al. 131I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: A nationwide population-based cohort study [J]. Eur J Nucl Med Mol Imag, 2015,42(8):1172-1178.
[14] Chow S. Side effects of high-dose radioactive iodine for ablation or treatment of differentiated thyroid carcinoma[J]. J HK Coll Radiol, 2005(8):127-135.
[15] Malpani BL, Samuel AM, Ray S. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine[J]. Int J Radiat Oncol Biol Phys, 1996,35(3):535-540.
[16] Geres AE, Mereshian PS, Fernández S, et al. Sialadenitis after radioiodine therapy: Analysis of factors that influence the response to medical treatment[J]. Endocrinol Nutr, 2015,62(10):493-498.
[17] Wu JQ, Feng HJ, Ouyang W, et al. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up[J]. Nucl Med Commun, 2015,36(8):819.
[18] Nahlieli O, Nazarian Y. Sialadenitis following radioiodine therapy a new diagnostic and treatment modality[J]. Oral Disease, 2006,12(5):476-479.
[19] Gonzalez ME, Muttikkal TJ, Rehm PK. Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen? (recombinant human thyroid stimulating hormone-thyrotropin alfa) [J]. J Radiol Case Rep, 2015,9(6):44-49.
[20] Prendes BL, Orloff LA, Eisele DW. Therapeutic sialendoscopy for the management of radioiodine sialadenitis[J]. Arch Otolaryngol Head Neck Surg, 2012,138(1):15-19.
文章导航

/